Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R McDougall

Showing results (11-20 of 217) with videos related to

Pageof 22
Sort By:
Scottish Medical Journal|January 1, 1978
Liposomes and vesiclesI R McDougall
The Western Journal of Medicine|July 1, 1992
Radionuclide therapy for thyroid diseaseI R McDougall
Nuclear Medicine Communications|June 1, 1997
74 MBq radioiodine 131I does not prevent uptake of therapeutic doses of 131I (i.e. it does not cause stunning) in differentiated thyroid cancerI R McDougall
Scottish Medical Journal|April 1, 1979
Stanford University Medical SchoolI R McDougall
Nuclear Medicine Communications|April 1, 1992
Letter from America (1991-92). AIDSI R McDougall
Nuclear Medicine Communications|July 15, 1999
Cancer deaths after 131I therapy for thyrotoxicosisI R McDougall
British Medical Journal|February 4, 1978
Arthritis simulating thrombosis on urokinase scanI R McDougall
Nuclear Medicine Communications|June 1, 1991
Letter from AmericaI R McDougall
Nuclear Medicine Communications|February 1, 1990
The importance of obtaining thyroid uptake measurement in patients with hyperthyroidismI R McDougall
Clinical Nuclear Medicine|October 1, 1995
Whole-body scintigraphy with radioiodine-131. A comprehensive list of false-positives with some examplesI R McDougall
Pageof 22

Showing results (11-20 of 217) with videos related to

Sort By:
Pageof 22
Scottish Medical Journal|January 1, 1978
Liposomes and vesiclesI R McDougall
The Western Journal of Medicine|July 1, 1992
Radionuclide therapy for thyroid diseaseI R McDougall
Nuclear Medicine Communications|June 1, 1997
74 MBq radioiodine 131I does not prevent uptake of therapeutic doses of 131I (i.e. it does not cause stunning) in differentiated thyroid cancerI R McDougall
Scottish Medical Journal|April 1, 1979
Stanford University Medical SchoolI R McDougall
Nuclear Medicine Communications|April 1, 1992
Letter from America (1991-92). AIDSI R McDougall
Nuclear Medicine Communications|July 15, 1999
Cancer deaths after 131I therapy for thyrotoxicosisI R McDougall
British Medical Journal|February 4, 1978
Arthritis simulating thrombosis on urokinase scanI R McDougall
Nuclear Medicine Communications|June 1, 1991
Letter from AmericaI R McDougall
Nuclear Medicine Communications|February 1, 1990
The importance of obtaining thyroid uptake measurement in patients with hyperthyroidismI R McDougall
Clinical Nuclear Medicine|October 1, 1995
Whole-body scintigraphy with radioiodine-131. A comprehensive list of false-positives with some examplesI R McDougall
Pageof 22